Clinical Trials Logo

Clinical Trial Summary

Phase I study of IMMH-010 in patients with advanced malignant solid tumors


Clinical Trial Description

To evaluate the safety and tolerability of single-dose and multi-dose IMMH-010 in patients with advanced solid tumors, et al. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04343859
Study type Interventional
Source Tianjin Chasesun Pharmaceutical Co., LTD
Contact
Status Enrolling by invitation
Phase Phase 1
Start date May 14, 2020
Completion date December 2024

See also
  Status Clinical Trial Phase
Terminated NCT01413386 - Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent N/A
Recruiting NCT05394428 - A Multi Center Study of Sexual Toxicities After Radiotherapy
Recruiting NCT05538130 - A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors Phase 1
Completed NCT00786656 - Community Cancer Centers Pilot Patient Survey
Recruiting NCT00026884 - Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Not yet recruiting NCT04881981 - A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer Phase 1
Recruiting NCT04416672 - Validation of the Italian Version of the PRO-CTCAE
Terminated NCT04543188 - A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement Phase 1
Completed NCT01512563 - Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent N/A
Active, not recruiting NCT04660929 - CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors Phase 1
Not yet recruiting NCT04202848 - The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
Recruiting NCT05315180 - A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors Phase 1